title: Emergence of YMDD mutant hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis.
authors.affiliation: Section of Hematology/oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
authors.forename: Yen-Chien
authors.initials: YC
authors.lastname: Lee
authors.forename: Kung-Chia
authors.initials: KC
authors.lastname: Young
authors.forename: Wu-Chou
authors.initials: WC
authors.lastname: Su
authors.forename: Chao-Jung
authors.initials: CJ
authors.lastname: Tsao
authors.forename: Tsai-Yun
authors.initials: TY
authors.lastname: Chen
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D016399:Lymphoma, T-Cell / Q000150:complications / Q000628:therapy; D009154:Mutation; D011292:Premedication / Q000379:methods; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D014019:Tissue Donors; D014184:Transplantation, Homologous
chemical_list: D000914:Antibodies, Viral; D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine